T1	Participants 49 85	severely immunocompromised patients.
T2	Participants 245 373	varicella-zoster virus infection in severely immunocompromised patients who presented within 72 hours of onset of the infection.
T3	Participants 374 417	Eleven patients were treated in each group.
T4	Participants 1306 1333	immunocompromised patients.
